Nomura expects Sun Pharma to earn USD 370 million in revenue during 6-month exclusivity period for Gleevec. It feels earnings support from Gleevec and Ranbaxy synergy limited downside risk.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
